Meropenem Injection IP 1g Seized Worth Rs 5.88 Lakhs For DPCO Violations

Mancherial: Today, Under the supervision of M. SrinivasuIu, AD, Karimnagar I, T.Chandana Drugs Inspector, Mancherial,  seized 118×1 gm vials of Asmero 1gm*(Meropenem Injection IP 1g) B.No: CI22159H, M/d: 09/2022,  E/D:  08/2024, Mfd. by: Curehealth pharmaceuticals Pvt Ltd, Vill. Raipur, P.O. Deothi, Tehsil & Dist. Solan, H.P and  Marketed by: Astam Healthcare Pvt Ltd, Vill. Theda, Teh. Nalagarh, Dist. Solan, H.P for the violation of  Para 13, 14(1) & (2) & 24 of DPCO 2013 r/w 1579(E) dated 31.03.2023.

Prices of 27 formulations were revised vide SO 1579(E) dtd 31.3.2023 with respect to WPI @12.1218%. Ceiling Price of Meropenem Injection IP 1g was originally fixed under NLEM, 2022. Ceiling price of this formulation is revised including WPI : Rs 952.68  for 1g vial on 31.3.2023.

Asmero1gm 1 is found printed with MRP on the label: Rs. 4200/- for 1g vial.

Ceiling price + GST(12%) is worked out to be  Rs 1067 per 1g vial.

As per DCOs, the formulation is printed with Excess : Rs. 3133/- per 1g vial.

Therefore, 1g vial is charged excess of  Rs 3133/- i.e., 293 % Excess MRP.  Total Worth of seized formulation is Rs.5,88,000/-

Related Posts

CDSCO Issues Directive for Strict Enforcement of Revised Schedule M Amid Drug Quality Concerns

NEW DELHI:  In a move to bolster pharmaceutical manufacturing standards across India, the Central Drugs Standard Control Organisation (CDSCO) has instructed state drug regulators to ensure rigorous compliance with the updated…

IIT Madras Researchers develop Affordable, Minimally Invasive Glucose Monitoring Device for Diabetes Patients

Chennai:  Indian Institute of Technology Madras (IIT Madras) researchers have developed and patented a cost-effective, user-friendly, and minimally invasive glucose monitoring device for diabetes patients. They have reimagined the device…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CDSCO Issues Directive for Strict Enforcement of Revised Schedule M Amid Drug Quality Concerns

CDSCO Issues Directive for Strict Enforcement of Revised Schedule M Amid Drug Quality Concerns

IIT Madras Researchers develop Affordable, Minimally Invasive Glucose Monitoring Device for Diabetes Patients

IIT Madras Researchers develop Affordable, Minimally Invasive Glucose Monitoring Device for Diabetes Patients

Rising Tide of Spurious Drugs in India: Recent Cases Highlight Nationwide Crackdown Amid Quality Concerns

Rising Tide of Spurious Drugs in India: Recent Cases Highlight Nationwide Crackdown Amid Quality Concerns

AGTF arrests man accused of smuggling drugs into USA by concealing them in granite lamps

AGTF arrests man accused of smuggling drugs into USA by concealing them in granite lamps

DCA raids expose steroid trade in Hyd gyms

DCA raids expose steroid trade in Hyd gyms

SPARSH Hospitals is poised to ‘Touch’ with Compassion Lives of Cancer Patients

SPARSH Hospitals is poised to ‘Touch’ with Compassion Lives of Cancer Patients